What is Pharmco Laboratories?
Established in 1979, Pharmco Laboratories operates as a premier U.S.-based contract manufacturer with a diverse portfolio spanning OTC pharmaceuticals, skincare, personal care, and pet care products. The company distinguishes itself by providing comprehensive, end-to-end manufacturing solutions that encompass everything from initial product development and formulation to complex packaging and stringent regulatory compliance services. By serving as a critical partner for both emerging brands and established global corporations, Pharmco Labs has cultivated a reputation for reliability and quality. Their market position is defined by an ability to navigate the complexities of supply chain management while maintaining the high standards required for retail-ready consumer goods.
How much funding has Pharmco Laboratories raised?
Pharmco Laboratories has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pharmco Laboratories
PPP
Public-Private Partnership
What's next for Pharmco Laboratories?
With the recent influx of capital, Pharmco Laboratories is poised to accelerate its strategic growth initiatives, likely focusing on the modernization of its production facilities and the integration of advanced automation technologies. As the company transitions through this late-stage funding phase, the primary objective will be to scale its operational capacity to accommodate increasing demand from major retail partners. Furthermore, the investment provides the necessary liquidity to bolster research and development efforts, ensuring that the firm remains at the forefront of formulation innovation and compliance excellence. This strategic pivot is expected to fortify their market share and enhance their value proposition as a leading provider of high-quality, compliant manufacturing solutions in an evolving consumer landscape.
See full Pharmco Laboratories company page
